Showing results (3001-3010 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 1, 1986
A phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study)J Arseneau, J A Blessing, F B Stehman, et al.Investigational New Drugs|June 4, 2018
Preclinical study of the antitumor effect of sphingosine-1-phosphate receptor 1 antibody (S1PR1-antibody) against human breast cancer cellsShujun Xiao, Jian YangInvestigational New Drugs|February 9, 2000
Protein kinase C targeting in antineoplastic treatment strategiesW D Jarvis, S GrantInvestigational New Drugs|February 9, 2000
Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical resultsS M Huang, P M HarariInvestigational New Drugs|July 30, 1999
Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusionI Rassmann, R Thödtmann, M Mross, et al.Investigational New Drugs|July 30, 1999
Phase II study of Didemnin B in central nervous system tumors: a Southwest Oncology Group studyS A Taylor, D J Giroux, K A Jaeckle, et al.Investigational New Drugs|November 11, 1999
Preclinical efficacy of thioxanthone SR271425 against transplanted solid tumors of mouse and human originT H Corbett, C Panchapor, L Polin, et al.Investigational New Drugs|November 11, 1999
Pharmacokinetics and metabolism of the staurosporine analogue CGP 41 251 in miceR van Gijn, O van Tellingen, E Haverkate, et al.Investigational New Drugs|November 11, 1999
Phase I clinical and pharmacokinetic study of an one-hour infusion of ormaplatin (NSC 363812)K D Tutsch, R Z Arzoomanian, D Alberti, et al.Investigational New Drugs|January 19, 2000
Phase II trial of suramin in patients with metastatic renal cell carcinomaR Dreicer, D C Smith, R D Williams, et al.Pageof 372